Edge Wealth Management LLC Global Blood Therapeutics, Inc. Transaction History

Edge Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 21, 2020	SELL	$52.76 - $74.49 $10,552 - $14,897	-200 Closed	0 $0
Q4 2018 Jan 11, 2019	SELL	$31.54 - $46.67 $6,308 - $9,334	-200 Reduced 50.0%	200 $8,000
Q3 2018 Oct 22, 2018	SELL	$38.0 - $51.1 $11,400 - $15,330	-300 Reduced 42.86%	400 $15,000
Q2 2018 Jul 17, 2018	BUY	$38.7 - $50.15 $19,350 - $25,075	500 Added 250.0%	700 $32,000
Q1 2018 Apr 05, 2018	SELL	$39.6 - $65.9 $19,800 - $32,950	-500 Reduced 71.43%	200 $10,000
Q4 2017 Jan 18, 2018	SELL	$29.7 - $45.7 $1,930 - $2,970	-65 Reduced 8.5%	700 $28,000
Q3 2017 Oct 19, 2017	BUY	$25.1 - $31.05 $19,201 - $23,753	765	765 $23,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.